30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Poseida Therapeutics, Inc. (PSTX)

Track

Stock chart
Ticker: PSTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gergen Mark J
Executive Chairman
1 sale — total 283,866 USD
Planned sale 10 Dec 2024
Value US$4,995,676.83 | Price 459.63 | Shares 30,519
Planned sale 26 Nov 2024
Value US$2,998,348.21 | Price 437.66 | Shares 55,677
Proposed sale 26 Nov 2024
Value US$343,200.00 | Price 2.86 | Shares 120,000
Planned buy 8 Aug 2022
Value US$499,999.50 | Price 3.50 | Shares 142,857
Buy 8 Aug 2022
Value US$7,525,000.00 | Price 3.50 | Shares 2,150,000
Planned sale 3 Aug 2022
Value US$592,807.54 | Price 3.69 | Shares 160,696
Buy 16 Mar 2022
Value US$11,940.00 | Price 3.98 | Shares 3,000
Buy 6 Dec 2021
Value US$12,613.20 | Price 6.90 | Shares 1,828
Buy 2 Dec 2021
Value US$29,550.47 | Price 6.88 | Shares 4,296
Buy 1 Dec 2021
Value US$125,805.76 | Price 6.85 | Shares 18,365
Buy 30 Nov 2021
Value US$195,838.04 | Price 6.85 | Shares 28,592
Buy 29 Nov 2021
Value US$76,209.27 | Price 6.89 | Shares 11,057
Buy 26 Nov 2021
Value US$185,492.11 | Price 6.81 | Shares 27,251
Buy 24 Nov 2021
Value US$7,260.16 | Price 6.89 | Shares 1,054
Buy 23 Nov 2021
Value US$98,989.31 | Price 6.77 | Shares 14,625
Buy 19 Nov 2021
Value US$82,650.40 | Price 7.44 | Shares 11,104
Buy 18 Nov 2021
Value US$511,684.99 | Price 7.18 | Shares 71,312
Buy 17 Nov 2021
Value US$14,000.00 | Price 7.00 | Shares 2,000
Buy 17 Nov 2021
Value US$2,021,820.99 | Price 7.21 | Shares 280,384
Buy 16 Nov 2021
Value US$198,382.56 | Price 7.17 | Shares 27,680
Planned sale 8 Nov 2021
Value US$64,171.59 | Price 7.09 | Shares 9,051
Planned sale 8 Nov 2021
Value US$69,999.57 | Price 7.09 | Shares 9,873
Planned sale 1 Oct 2021
Value US$67,244.58 | Price 7.02 | Shares 9,579
Planned sale 1 Oct 2021
Value US$73,359.00 | Price 7.02 | Shares 10,450
Planned sale 11 Jun 2021
Value US$37,747.20 | Price 9.44 | Shares 4,000
Planned sale 4 May 2021
Value US$145,260.84 | Price 8.44 | Shares 17,211
Planned sale 4 May 2021
Value US$158,461.00 | Price 8.44 | Shares 18,775
Planned sale 3 May 2021
Value US$78,972.65 | Price 9.01 | Shares 8,765
Planned sale 3 May 2021
Value US$86,144.61 | Price 9.01 | Shares 9,561
Planned sale 5 Apr 2021
Value US$15,307.38 | Price 10.32 | Shares 1,483
Planned sale 5 Apr 2021
Value US$251,886.25 | Price 9.63 | Shares 26,170
Planned sale 5 Apr 2021
Value US$16,690.51 | Price 10.32 | Shares 1,617
Planned sale 5 Apr 2021
Value US$274,784.12 | Price 9.63 | Shares 28,549
Planned sale 1 Apr 2021
Value US$261,284.18 | Price 9.55 | Shares 27,347
Planned sale 1 Apr 2021
Value US$285,045.97 | Price 9.55 | Shares 29,834
Planned sale 2 Mar 2021
Value US$314,899.31 | Price 11.54 | Shares 27,290
Planned sale 2 Mar 2021
Value US$343,516.03 | Price 11.54 | Shares 29,770
Planned sale 1 Mar 2021
Value US$5,866.08 | Price 12.12 | Shares 484
Planned sale 1 Mar 2021
Value US$317,455.16 | Price 11.66 | Shares 27,226
Planned sale 1 Mar 2021
Value US$6,399.36 | Price 12.12 | Shares 528
Planned sale 1 Mar 2021
Value US$346,325.32 | Price 11.66 | Shares 29,702
Planned sale 16 Feb 2021
Value US$1,332,035.91 | Price 10.00 | Shares 133,149
Planned sale 10 Feb 2021
Value US$123,890.00 | Price 10.00 | Shares 12,389
Planned sale 21 Jan 2021
Value US$44,620.00 | Price 10.00 | Shares 4,462
Buy 14 Jul 2020
Value US$4,000,000.00 | Price 16.00 | Shares 250,000
Buy 14 Jul 2020
Value US$160,000.00 | Price 16.00 | Shares 10,000
Buy 14 Jul 2020
Value US$160,000.00 | Price 16.00 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-11 2024-12-10 PlS Planned sale
Gergen Mark J

Executive Chairman

Executive Director
30,519 +22.0%
459.63
US$4,995,677 		30,519 +22.0% 459.63 US$4,995,677
2024-11-27 2024-11-26 PlS Planned sale
Gergen Mark J

Executive Chairman

Executive Director
55,677 -3.9%
437.66
US$2,998,348 		55,677 -3.9% 437.66 US$2,998,348
2024-11-26 2024-11-26 PrS Proposed sale
MARK GERGEN

Director; Officer

Executive Director
6,063
142.78
US$713,371 		6,063 142.78 US$713,371
2022-08-10 2022-08-08 PP Planned purchase
Ostertag Eric

Executive Chairman

Executive Director Large shareholder
142,857 +20.5%
3.50
US$500,000 		142,857 +20.5% 3.50 US$500,000
2022-08-10 2022-08-08 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
2,150,000 +22.2%
3.50
US$7,525,000 		2,150,000 +22.2% 3.50 US$7,525,000
2022-08-05 2022-08-03 PlS Planned sale
Ostertag Eric

Executive Chairman

Executive Director Large shareholder
160,696 -100.0%
3.69
US$592,808 		160,696 -100.0% 3.69 US$592,808
2022-03-18 2022-03-16 B Purchase
1.1
Ingalls Kerry D.

Chief Operating Officer

Officer
3,000 +5.8%
3.98
US$11,940 		3,000 +5.8% 3.98 US$11,940
2021-12-07 2021-12-06 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
1,828 +0.0%
6.90
US$12,613 		1,828 +0.0% 6.90 US$12,613
2021-12-02 2021-12-02 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
4,296 +0.0%
6.88
US$29,550 		4,296 +0.0% 6.88 US$29,550
2021-12-02 2021-12-01 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
18,365 +0.2%
6.85
US$125,806 		18,365 +0.2% 6.85 US$125,806
2021-12-02 2021-11-30 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
28,592 +0.3%
6.85
US$195,838 		28,592 +0.3% 6.85 US$195,838
2021-11-29 2021-11-29 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
11,057 +0.1%
6.89
US$76,209 		11,057 +0.1% 6.89 US$76,209
2021-11-29 2021-11-26 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
27,251 +0.3%
6.81
US$185,492 		27,251 +0.3% 6.81 US$185,492
2021-11-29 2021-11-24 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
1,054 +0.0%
6.89
US$7,260 		1,054 +0.0% 6.89 US$7,260
2021-11-23 2021-11-23 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
14,625 +0.2%
6.77
US$98,989 		14,625 +0.2% 6.77 US$98,989
2021-11-23 2021-11-19 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
11,104 +0.1%
7.44
US$82,650 		11,104 +0.1% 7.44 US$82,650
2021-11-18 2021-11-18 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
71,312 +0.8%
7.18
US$511,685 		71,312 +0.8% 7.18 US$511,685
2021-11-18 2021-11-17 B Purchase
1.1
Ingalls Kerry D.

Chief Operating Officer

Officer
2,000 +inf%
7.00
US$14,000 		2,000 +inf% 7.00 US$14,000
2021-11-18 2021-11-17 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
280,384 +3.0%
7.21
US$2,021,821 		280,384 +3.0% 7.21 US$2,021,821
2021-11-18 2021-11-16 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
27,680 +0.3%
7.17
US$198,383 		27,680 +0.3% 7.17 US$198,383
2021-11-10 2021-11-08 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,051 -0.3%
7.09
US$64,172 		9,051 -0.3% 7.09 US$64,172
2021-11-10 2021-11-08 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,873 -0.3%
7.09
US$70,000 		9,873 -0.3% 7.09 US$70,000
2021-10-05 2021-10-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,579 -0.3%
7.02
US$67,245 		9,579 -0.3% 7.02 US$67,245
2021-10-05 2021-10-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
10,450 -0.3%
7.02
US$73,359 		10,450 -0.3% 7.02 US$73,359
2021-06-14 2021-06-11 PlS Planned sale
Spear Matthew A.

Chief Medical Officer

Officer
4,000 -19.5%
9.44
US$37,747 		4,000 -19.5% 9.44 US$37,747
2021-05-05 2021-05-04 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
17,211 -0.5%
8.44
US$145,261 		17,211 -0.5% 8.44 US$145,261
2021-05-05 2021-05-04 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
18,775 -0.5%
8.44
US$158,461 		18,775 -0.5% 8.44 US$158,461
2021-05-05 2021-05-03 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
8,765 -0.2%
9.01
US$78,973 		8,765 -0.2% 9.01 US$78,973
2021-05-05 2021-05-03 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,561 -0.2%
9.01
US$86,145 		9,561 -0.2% 9.01 US$86,145
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
1,483 -0.0%
10.32
US$15,307 		1,483 -0.0% 10.32 US$15,307
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
26,170 -0.7%
9.63
US$251,886 		26,170 -0.7% 9.63 US$251,886
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
1,617 -0.0%
10.32
US$16,691 		1,617 -0.0% 10.32 US$16,691
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
28,549 -0.7%
9.63
US$274,784 		28,549 -0.7% 9.63 US$274,784
2021-04-05 2021-04-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
27,347 -0.8%
9.55
US$261,284 		27,347 -0.8% 9.55 US$261,284
2021-04-05 2021-04-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
29,834 -0.8%
9.55
US$285,046 		29,834 -0.8% 9.55 US$285,046
2021-03-03 2021-03-02 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
27,290 -0.8%
11.54
US$314,899 		27,290 -0.8% 11.54 US$314,899
2021-03-03 2021-03-02 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
29,770 -0.8%
11.54
US$343,516 		29,770 -0.8% 11.54 US$343,516
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
484 -0.0%
12.12
US$5,866 		484 -0.0% 12.12 US$5,866
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
27,226 -0.7%
11.66
US$317,455 		27,226 -0.7% 11.66 US$317,455
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
528 -0.0%
12.12
US$6,399 		528 -0.0% 12.12 US$6,399
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
29,702 -0.7%
11.66
US$346,325 		29,702 -0.7% 11.66 US$346,325
2021-02-17 2021-02-16 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
133,149 -39.9%
10.00
US$1,332,036 		133,149 -39.9% 10.00 US$1,332,036
2021-02-12 2021-02-10 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
12,389 -3.6%
10.00
US$123,890 		12,389 -3.6% 10.00 US$123,890
2021-01-25 2021-01-21 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
4,462 -1.3%
10.00
US$44,620 		4,462 -1.3% 10.00 US$44,620
2020-07-15 2020-07-14 B Purchase
1.2
Hirsch David
Non-Executive Director
250,000 +10.1%
16.00
US$4,000,000 		250,000 +10.1% 16.00 US$4,000,000
2020-07-15 2020-07-14 B Purchase
3.2
Murphy Sean
Non-Executive Director Large shareholder
10,000 +inf%
16.00
US$160,000 		10,000 +inf% 16.00 US$160,000
2020-07-15 2020-07-14 B Purchase
Lloyd Marcea Bland
Non-Executive Director
10,000 +inf%
16.00
US$160,000 		10,000 +inf% 16.00 US$160,000
Explore more

More insider trading research around Poseida Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America